...
首页> 外文期刊>European journal of ophthalmology >Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes
【24h】

Efficacy of addition of nepafenac 0.1% to steroid eye drops in prevention of post-phaco macular edema in high-risk eyes

机译:Nepafenac 0.1%的疗效在高风险的眼睛中预防验源后神经皮疹的疗效滴落

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To compare the efficacy of addition of nonsteroidal anti-inflammatory eye drops to steroidal eye drops with that of using postoperative steroidal anti-inflammatory eye drops alone in prevention of macular edema in high-risk patients. Setting: Cairo University Hospital. Design: This study was comparative prospective interventional randomized study. Methods: This study included 100 cataractous eyes divided into five subgroups: 20 eyes of diabetic patients, 20 uveitic eyes, 20 traumatic cataracts, 20 glaucomatous eyes on topical prostaglandin analogs, and 20 eyes with posterior capsular rupture during phacoemulsification. Each subgroup of 20 was randomized between two groups of 10 eyes, group A received postoperative topical steroids alone and group B received both steroidal and nonsteroidal anti-inflammatory eye drops. Results: There was significant increase in postoperative central foveal thickness as compared to preoperative values in both groups (60.9 +/- 87.95 mu in group A and 25.52 +/- 57.26 mu in group B) that was significantly more in group A (P value 0.016). There was significant difference in postoperative macular thickness between both groups (280.1 +/- 86.0 mu and 246.80 +/- 57.73 mu, respectively, in groups A and B) (P value = 0.012). There was no statistically significant difference between both groups in preoperative and postoperative corrected distance visual acuity and intraocular pressure. Conclusion: Addition of topical nepafenac eye drops to topical steroid drops significantly reduced the amount of pseudophakic macular edema after cataract surgery in high-risk eyes.
机译:目的:比较非甾体抗炎症滴滴涕对甾体症滴眼液的疗效与使用术后甾体抗炎眼药水单独用于预防高危患者的黄斑水肿。环境:开罗大学医院。设计:本研究具有比较前瞻性介入随机研究。方法:本研究包括100个白线眼睛分为五个亚组:20只糖尿病患者的眼睛,20只羽毛眼,20个创伤性白内障,20个胶囊术,在局部前列腺素类似物中,20只眼睛在沉重乳化过程中具有后囊破裂的眼睛。每组20个亚组在两组10只眼内随机化,仅接受术后局部类固醇,B组接受甾体和非甾体抗炎眼滴。结果:与两组的术前值相比,术后中央污水厚度显着增加(A组A和25.52 + / -57.26亩),在A组中明显更多(P值0.016)。两组之间的术后黄斑厚度有显着差异(分别在A和B组中分别为280.1 +/-86.0μm和246.80 +/-57.73μm)(P值= 0.012)。在术前和术后校正距离视力和眼内压力中,这两个组之间没有统计学上的显着差异。结论:局部Nepafenac滴眼液向局部类固醇滴剂显着降低了高风险眼层白内障手术后伪黄斑水肿的量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号